…
Coromandel International Limited provides agriculture solutions in India and internationally. It operates through the Nutrient and Other Allied Business, and Crop Protection segments. The company offers fertilizers, including GroPlus Pro Mg and Gromor Urea Super Phosphate; bio-products comprising MycoRitz and Grovibe; specialty nutrients, such as Pixibud, Pixigrow, Nano Urea, Areca Shakti, and Coffee Bliss; and crop protection products that include Caveco, Marvex, Prachand, Benofit, Rukawat X, Myconil, Eezykil Ultra, Cortus, Victini Z, and Toscee. It also provides value-added services, including drone spraying, soil testing, crop diagnostics, and weather insights, as well as e-commerce platform for advisory and ordering. The company was formerly known as Coromandel Fertilisers Ltd and changed its name to Coromandel International Limited in September 2009. Coromandel International Limited was incorporated in 1961 and is based in Chennai, India. Coromandel International Limited operates as a subsidiary of E.I.D.-Parry (India) Limited.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 27275.50M | 21884.50M | 27008.40M | 20497.50M | 17859.50M |
| Minority interest | 117.50M | 15.50M | - | - | 0.00M |
| Net income | 20664.60M | 16421.90M | 20129.30M | 15284.60M | 13291.50M |
| Selling general administrative | 433.20M | 413.60M | 367.20M | 336.10M | 278.90M |
| Selling and marketing expenses | 13433.90M | 11620.90M | 11384.10M | 10333.60M | 8923.60M |
| Gross profit | 61029.90M | 54753.80M | -85483.50M | -20413.80M | 10362.20M |
| Reconciled depreciation | 2903.90M | 2285.60M | 1819.50M | 1726.50M | 1730.80M |
| Ebit | 24247.10M | 22158.70M | 28672.50M | 21196.70M | 18851.40M |
| Ebitda | 26655.10M | 24015.90M | 30492.00M | 22923.20M | 20582.20M |
| Depreciation and amortization | 2408.00M | 1857.20M | 1819.50M | 1726.50M | 1730.80M |
| Operating income | 52619.70M | 47479.00M | 29105.80M | 20461.00M | 18649.60M |
| Other operating expenses | 188232.70M | 173104.90M | 122119.20M | 102397.30M | 89434.70M |
| Interest expense | 2624.30M | 1865.70M | 1791.70M | 678.50M | 983.50M |
| Tax provision | 6728.40M | 5478.10M | 6879.10M | 5212.90M | 4568.00M |
| Interest income | 462.00M | 1917.20M | 2117.70M | 717.30M | 1002.70M |
| Net interest income | -2624.30M | -1865.70M | -318.20M | -754.70M | -1056.70M |
| Income tax expense | 6728.40M | 5478.10M | 6879.10M | 5212.90M | 4568.00M |
| Total revenue | 240852.40M | 220583.90M | 151226.60M | 123232.10M | 108375.70M |
| Total operating expenses | 8410.20M | 7274.80M | -114590.90M | -41248.60M | -8578.80M |
| Cost of revenue | 179822.50M | 165830.10M | 236710.10M | 143645.90M | 98013.50M |
| Total other income expense net | -25344.20M | -25594.50M | -2097.40M | 36.50M | -790.10M |
| Net income from continuing ops | 20547.10M | 16406.40M | 20129.30M | 15284.60M | 13291.50M |
| Net income applicable to common shares | 20664.60M | 16421.90M | 20129.30M | 15284.60M | 13291.50M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 189276.20M | 158515.00M | 142348.00M | 112847.40M | 88956.60M |
| Intangible assets | 7394.70M | 681.30M | 320.80M | 287.60M | 227.40M |
| Other current assets | 28318.50M | 25573.10M | 4213.40M | 5227.90M | 1898.20M |
| Total liab | 77048.60M | 64046.70M | 63270.10M | 49264.70M | 37450.70M |
| Total stockholder equity | 110878.30M | 94199.00M | 79077.90M | 63582.70M | 51505.90M |
| Other current liab | 7787.50M | 4207.90M | 1483.80M | 1867.30M | 136.90M |
| Common stock | 294.60M | 294.40M | 294.00M | 293.50M | 293.40M |
| Capital stock | 294.60M | 294.00M | 294.00M | 293.50M | 293.40M |
| Retained earnings | 84443.60M | 67988.10M | 52787.10M | 36229.90M | 24444.70M |
| Other liab | - | - | - | 899.90M | 813.10M |
| Good will | 2849.30M | 2849.30M | 3.20M | 3.20M | 3.20M |
| Other assets | 239.70M | 103.80M | 41.20M | 4682.80M | 553.40M |
| Cash | 2547.50M | 11247.60M | 13937.50M | 7060.10M | 6921.00M |
| Cash and equivalents | 1835.50M | 10325.90M | - | - | 77.80M |
| Total current liabilities | 69903.70M | 58635.50M | 58564.90M | 44655.90M | 33018.50M |
| Current deferred revenue | - | 2.60M | 3648.40M | 3412.50M | 3429.60M |
| Net debt | -27579.60M | -6326.40M | -10011.70M | -3110.50M | -3071.50M |
| Short term debt | 1816.10M | 818.60M | 295.00M | 240.70M | 230.40M |
| Short long term debt | 1469.00M | 517.90M | 46.00M | 0.40M | 16.10M |
| Short long term debt total | 7803.80M | 4921.20M | 3925.80M | 3949.60M | 3849.50M |
| Other stockholder equity | 2076.50M | 2109.60M | 25996.80M | 27059.30M | 26767.80M |
| Property plant equipment | 35108.30M | 29941.10M | 25673.40M | 22036.90M | 20821.60M |
| Total current assets | 132307.60M | 121230.30M | 102436.10M | 83402.30M | 65213.10M |
| Net tangible assets | - | - | - | 63291.90M | 51275.30M |
| Short term investments | 41353.30M | 6229.60M | 1.10M | 10243.00M | 665.70M |
| Net receivables | 12290.90M | 13935.40M | 40119.60M | 24239.00M | 30385.10M |
| Long term debt | 853.30M | 0.00M | - | - | - |
| Inventory | 47699.10M | 46125.00M | 44164.50M | 36632.30M | 26008.80M |
| Accounts payable | 60300.10M | 53606.40M | 53137.70M | 39135.40M | 29221.60M |
| Accumulated other comprehensive income | 24062.50M | 23904.40M | - | - | - |
| Non currrent assets other | 1974.80M | 492.50M | 41.00M | 44.80M | 14.90M |
| Non current assets total | 56968.60M | 37284.70M | 39911.90M | 29445.10M | 23743.50M |
| Capital lease obligations | 5481.50M | 4403.30M | 3879.80M | 3949.20M | 3833.40M |
| Long term debt total | 5987.70M | 4102.60M | 3630.80M | 3708.90M | 3619.10M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -26376.90M | -13342.80M | 6390.40M | -16219.90M | 4.00M |
| Change to liabilities | - | - | - | 10162.70M | -2895.60M |
| Total cashflows from investing activities | -26376.90M | -13342.80M | 6390.40M | -16219.90M | -12572.30M |
| Net borrowings | -516.10M | 471.90M | - | -605.10M | -16424.30M |
| Total cash from financing activities | -6978.20M | -3632.10M | -5430.50M | -4425.20M | -22631.60M |
| Change to operating activities | - | - | - | 1273.40M | 17063.80M |
| Net income | 20664.60M | 16421.90M | 27008.40M | 20497.50M | 17859.50M |
| Change in cash | -8700.10M | -2690.00M | 6877.50M | 139.10M | 6415.60M |
| Begin period cash flow | 11247.60M | 13937.60M | 7060.10M | 6921.00M | 505.40M |
| End period cash flow | 2547.50M | 11247.60M | 13937.60M | 7060.10M | 6921.00M |
| Total cash from operating activities | 24636.10M | 14276.90M | 5909.70M | 20780.50M | 41501.50M |
| Issuance of capital stock | 167.70M | 166.00M | 196.30M | 43.40M | 143.80M |
| Depreciation | 2903.90M | 2285.60M | 1819.50M | 1726.50M | 1730.80M |
| Other cashflows from investing activities | -1181.10M | 874.10M | 12442.80M | -13454.00M | -10530.70M |
| Dividends paid | 3528.20M | 1855.70M | -3526.40M | -3521.30M | -5277.20M |
| Change to inventory | -1402.00M | -1852.00M | -7532.20M | -10623.50M | 1082.50M |
| Change to account receivables | 1622.20M | 2013.10M | -3296.50M | 2903.80M | 11697.50M |
| Sale purchase of stock | -154.80M | -249.40M | 196.30M | 43.40M | 16091.30M |
| Other cashflows from financing activities | -2779.10M | -2164.90M | -2100.40M | -947.30M | -17354.40M |
| Change to netincome | - | - | - | 53.00M | -469.00M |
| Capital expenditures | 8506.40M | 5268.90M | 6052.40M | 2779.20M | 1950.40M |
| Change in working capital | 4520.30M | -3575.40M | -16520.20M | 3716.40M | 26948.20M |
| Stock based compensation | 106.10M | 63.00M | 77.10M | 28.10M | 39.90M |
| Other non cash items | -3558.80M | -918.20M | 308.90M | -270.20M | 637.60M |
| Free cash flow | 16129.70M | 9008.00M | -142.70M | 18001.30M | 39551.10M |
Sector: Basic Materials Industry: Agricultural Inputs
|
Stock Name
|
Change
(INR) |
Price
(INR) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| COROMANDEL Coromandel International Limited |
- -% |
1824.00 | 27.92 | - | 2.34 | 5.61 | 3.20 | 17.09 |
| UPL UPL Limited |
- -% |
534.90 | 30.63 | 26.45 | 1.41 | 2.13 | 1.96 | 11.16 |
| FACT Fertilizers and Chemicals Travancore Limited |
-8.45 1.11% |
751.20 | 567.61 | - | 12.34 | 41.13 | 18.86 | 139.84 |
| PIIND PI Industries Limited |
- -% |
1735.00 | 32.51 | 46.51 | 6.60 | 4.60 | 6.25 | 19.62 |
| SUMICHEM Sumitomo Chemical India Limited |
- -% |
328.95 | 41.43 | - | 6.81 | 7.18 | 6.51 | 26.60 |
Coromandel International Limited provides agriculture solutions in India and internationally. It operates through the Nutrient and Other Allied Business, and Crop Protection segments. The company offers fertilizers, including GroPlus Pro Mg and Gromor Urea Super Phosphate; bio-products comprising MycoRitz and Grovibe; specialty nutrients, such as Pixibud, Pixigrow, Nano Urea, Areca Shakti, and Coffee Bliss; and crop protection products that include Caveco, Marvex, Prachand, Benofit, Rukawat X, Myconil, Eezykil Ultra, Cortus, Victini Z, and Toscee. It also provides value-added services, including drone spraying, soil testing, crop diagnostics, and weather insights, as well as e-commerce platform for advisory and ordering. The company was formerly known as Coromandel Fertilisers Ltd and changed its name to Coromandel International Limited in September 2009. Coromandel International Limited was incorporated in 1961 and is based in Chennai, India. Coromandel International Limited operates as a subsidiary of E.I.D.-Parry (India) Limited.
Olympia Terraces, No. 15B(SP), Chennai, India, 600032
91 44 4252 5300
5540
| Name | Title | Year Born |
|---|---|---|
| Mr. Sameer Goel | MD & Exec. Director | 1963 |
| Mr. Arun Alagappan | Exec. Vice Chairman | 1976 |
| Ms. Jayashree Satagopan | CFO & Exec. VP | 1968 |
| Dr. Amit Rastogi B.Tech (Chem), M.S.(Chem), Ph.D.(Chem) | Exec. VP of Technology | 1965 |
| Mr. Rajesh Mukhija | Sr. VP of Legal, Company Sec. & Compliance Officer | NA |
| Mr. Kalidas Pramanik | Exec. VP, Head of Sales and Marketing - Fertilisers & Organic | 1968 |
| Mr. Pradeep Kumar K | Exec. VP & Head of HR | NA |
| Mr. Arun Leslie George | Head of Retail & Exec. VP | 1967 |
| Mr. S. Sankarasubramanian B.Sc, ICWA | Pres of Nutrient Bus. | 1969 |
| Mr. Majoj Kumar Agarwal | Sr. VP & Head of Corp. Strategic Planning | 1966 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.